Related by context. All words. (Click for frequent words.) 79 pharmacological 66 antiangiogenic 66 antithrombotic 66 neuroprotection 65 insulin sensitizing 65 immunomodulatory 65 mTOR inhibitors 65 glucose lowering 65 antidepressive 65 pharmacological approaches 65 pharmacologic approaches 64 pharmacotherapies 64 neurogenic 64 nonpharmacologic 64 neuroregenerative 64 hypotensive 63 anti angiogenic 63 analgesic effects 63 physiologic 63 disease modifying 63 erythropoietic 63 immunomodulating 63 pharmacodynamic 63 anxiolytic 63 pharmacotherapeutic 63 receptor antagonists 63 pharmacological interventions 63 fulvestrant 63 β blockers 63 antiinflammatory 63 pharmacodynamic PD 63 primidone 63 vidofludimus 63 antiarrhythmic 63 anti leukemic 63 antitumor 63 antidiabetic 63 dopaminergic 63 neuroleptics 63 NMDA antagonist 63 renoprotective 63 pharmacokinetic interactions 63 immune modulating 62 pharmacological intervention 62 multitargeted 62 #ME# 62 intracoronary 62 cytoprotective 62 receptor subtypes 62 VAPRISOL 62 serotonergic 62 neuroprotective 62 analgesic 62 intravenous cyclophosphamide 62 neuroprotective agent 62 immunomodulatory effects 62 lipid lowering therapies 62 pharmacological therapies 62 neurotrophic 62 favorable pharmacokinetic profile 62 immunomodulation 62 NMDA antagonists 62 uric acid lowering 61 efficacy tolerability 61 antitumor effect 61 itraconazole 61 anti VEGF 61 muscarinic 61 direct thrombin inhibitors 61 nonpharmacological 61 pharmacologically 61 receptor agonists 61 anti fibrotic 61 antiplatelet therapies 61 lipid parameters 61 partial agonists 61 glucocorticoid 61 antiemetics 61 antiresorptive 61 Hsp# inhibitors 61 psychopharmacologic 61 selective inhibition 61 APTIVUS r 61 mecamylamine 61 antifibrotic 61 antithrombotic therapy 61 neuroleptic 61 antiplatelet agents 61 opioid induced 61 microtubule targeting 61 antihypertensive agents 61 TNF inhibitor 61 HMG CoA reductase inhibitors 61 vasodilatory 61 tricyclic 61 antihypertensive therapy 61 PDE4 inhibitors 61 anti angiogenic drugs 61 anticholinergic agents 61 inotropic 61 anti amnesic 60 partial agonist 60 factor TNF 60 alagebrium 60 IL 1ß 60 immune modulation 60 diabetic gastroparesis 60 selective modulator 60 favorable pharmacokinetic 60 clomipramine 60 beta adrenergic 60 urate lowering 60 antitumoral 60 neuro protective 60 renin angiotensin aldosterone 60 anticholinergic 60 neuroprotectant 60 pyridostigmine 60 immunosuppressive agents 60 Symadex 60 TRV# [001] 60 velafermin 60 cardioprotection 60 anti angiogenic agents 60 idarubicin 60 anti secretory 60 Pharmacological 60 antiemetic 60 pharmacological treatments 60 insulin sensitizers 60 antiapoptotic 60 antiplatelet 60 mu opioid 60 peripherally acting 60 overlapping toxicities 60 bronchodilation 60 posaconazole 60 HCV protease inhibitors 60 isoproterenol 60 gastrointestinal motility 60 platelet activation 60 therapeutic 60 pharmacologic stress 60 viral kinetics 60 L dopa 60 endothelin receptor antagonists 60 postoperative ileus POI 60 metabolic parameters 59 therapies 59 thiazide diuretic 59 pharmacokinetic parameters 59 fibrinolytic 59 glucose homeostasis 59 act synergistically 59 cortical stimulation 59 preclinically 59 incretin 59 LHRH antagonists 59 LDL cholesterol lowering 59 antihypertensive drugs 59 agomelatine 59 SERMs 59 pharmacologic treatments 59 agonism 59 immunoregulatory 59 potentiation 59 adrenergic 59 phenelzine 59 pharmacologic intervention 59 intravesical 59 chemosensitivity 59 pharmacotherapy 59 rufinamide 59 pharmacologic agents 59 non steroidal 59 antirheumatic 59 busulfan 59 glucocorticoid receptor 59 analgesic medications 59 p# activation 59 flecainide 59 neuroprotective properties 59 doxorubicin HCl 59 selective antagonist 59 immune suppressive 59 liposomal formulation 59 antiproliferative 59 pramlintide metreleptin combination 59 interferon IFN 59 TNF alpha inhibitor 59 mycophenolate mofetil 59 MMP inhibitors 59 immunostimulatory 59 clinically meaningful 59 antidiabetic drugs 59 antiepileptic 59 adipiplon 59 inotropes 59 idraparinux 59 PXD# 59 underlying pathophysiology 59 hydroxychloroquine 59 anticancer treatments 59 monoamine oxidase inhibitors 59 pro angiogenic 59 TNFalpha 59 molecularly targeted 59 antidepressant efficacy 59 pharmacodynamic endpoints 59 hypercholesterolemia 59 pharmacodynamic parameters 59 N acetylcysteine 59 adenosine receptor 59 CB2 receptor 59 cardiac toxicity 59 chemopreventive agent 59 immunostimulatory effects 59 paricalcitol 59 VEGF pathway 59 REG1 59 immune modulatory 59 mitochondrial toxicity 59 opioid antagonists 59 DFMO 59 pertuzumab 59 dopamine agonists 59 potent inhibitors 59 antihyperglycemic 59 sotalol 59 GnRH agonists 59 statins cholesterol lowering 59 norepinephrine reuptake inhibition 59 immunosuppressive 59 nicotinic acetylcholine receptor 59 CB1 antagonists 59 anti atherogenic 59 Valdoxan 59 psychotherapeutic interventions 59 HIF PH inhibitors 59 leukotriene receptor antagonists 58 CB1 receptor 58 Aliskiren 58 PPAR gamma agonists 58 antiangiogenic agents 58 anticancer therapy 58 potent antiproliferative 58 geldanamycin 58 tezampanel 58 interventional therapies 58 pharmacodynamic profile 58 gemcitabine Gemzar 58 antithrombotics 58 potentiator 58 pharmacodynamics PD 58 calcineurin inhibitors 58 imexon 58 analgesic efficacy 58 teriflunomide 58 EGFR inhibitors 58 neurohormonal 58 peptidic 58 fosbretabulin 58 glucagon receptor 58 Bisphosphonate 58 anti proliferative 58 OXi# 58 pathophysiologic 58 bronchodilators 58 opioid analgesia 58 angiotensin receptor blocker ARB 58 lenalidomide dexamethasone 58 riociguat 58 coadministration 58 VEGF inhibitors 58 potent neuroprotective 58 systemically administered 58 serotonin reuptake 58 ACh 58 clinically relevant 58 opioid receptor antagonist 58 ziconotide 58 thalidomide Thalomid 58 MGd 58 receptor antagonism 58 inotropic agents 58 guanfacine 58 reperfusion injury 58 immunomodulatory therapy 58 neuroprotective effects 58 vWF 58 somatostatin analogs 58 LDL lowering 58 PSN# [002] 58 neuroinflammatory 58 cardiac repolarization 58 alkylating agent 58 erlotinib Tarceva ® 58 lipid lowering agents 58 prodrugs 58 lipid lowering 58 clevidipine 58 immunological 58 erlotinib Tarceva 58 tumor necrosis 58 biologic therapy 58 anticancer activity 58 PPAR gamma agonist 58 galanin 58 vasodilator 58 antiepileptics 58 GMX# 58 hepatotoxic 58 anti resorptive 58 serotonin receptor 58 anti Parkinsonian 58 antiarrhythmic drug 58 insulin sensitizer 58 PRT# 58 chemotherapeutic agents 58 VEGF receptor 58 Squalamine 58 aromatase inhibitors AIs 58 immunosuppressive regimens 58 overactive bladder symptoms 58 cannabinor 58 Teriflunomide 58 antimuscarinic 58 mGluR2 58 bronchodilatory 58 chronic neuropathic pain 58 beta interferons 58 vasodilators 58 cardiotoxic 58 non selective NMDA 58 HPA axis 58 ropinirole Requip 58 antibody mediated 58 DMARD 58 pharmacokinetic properties 58 tolvaptan 58 thiazolidinedione 58 AChE inhibitors 58 GLP 1R 58 GFT# 58 therapeutic regimens 58 chemopreventive 58 dyskinesias 58 glycemia 58 pharmacodynamic properties 58 HDAC inhibition 58 ibudilast 58 cardiac valvulopathy 58 rHuPH# 58 intranasal corticosteroids 58 teriparatide 58 TriRima 58 TNFα 58 prostanoid 58 CXB# 58 pharmacodynamic effects 58 deacetylase inhibitors 58 cerebral ischemia 58 phosphodiesterase inhibitors 58 nephrotoxic 58 TRIOLEX 58 therapeutic interventions 58 pharmacologic therapies 58 hyperalgesia 57 long acting bronchodilator 57 alpha blocker 57 p# inhibitor 57 mapatumumab 57 nanoviricide 57 immune modulator 57 immunosuppressive regimen 57 antihypertensive 57 Traficet EN 57 dopamine agonist 57 immunosuppressive therapies 57 Src inhibitors 57 airway responsiveness 57 natriuretic 57 #beta HSD1 57 cilengitide 57 zileuton 57 triptan 57 Vaprisol 57 metastatic RCC 57 caspofungin 57 cannabinoid receptor 57 TACE 57 prokinetic 57 IFN beta 57 receptor inhibitor 57 EGFR tyrosine kinase inhibitors 57 experimentally induced 57 anti CD3 57 vivo 57 histone deacetylase inhibitors 57 trodusquemine 57 gefitinib Iressa 57 electrophysiologic 57 eniluracil 57 antifolates 57 EGFR antibodies 57 tumor vasculature 57 XmAb# 57 mTOR signaling 57 INVEGA ® 57 dosing frequency 57 hemodynamic 57 renal toxicity 57 pro apoptotic 57 oxcarbazepine 57 etiologic 57 Aggrastat ® tirofiban hydrochloride 57 5 HT1A 57 CGRP 57 conventional DMARDs 57 PI3K inhibitors 57 retinoid 57 angiotensin II receptor blockers 57 potassium sparing diuretics 57 immunomodulatory agents 57 VDAs 57 xenograft models 57 oral prodrug 57 HER2 overexpression 57 beta agonists 57 pathophysiological 57 echinocandins 57 molecular biomarkers 57 5 HT2A receptor 57 diabetic neuropathy 57 cardioprotective effects 57 mGluR5 inhibition 57 efficacy 57 cardio protective 57 vascular disrupting agents 57 LPA1 receptor 57 cytostatic 57 mGluR5 antagonist 57 GHRH 57 trastuzumab Herceptin ® 57 somatostatin 57 HSP# inhibitor 57 paclitaxel Taxol 57 MEVACOR 57 cytotoxic agents 57 aldosterone antagonists 57 verapamil 57 CCR2 57 endotoxemia 57 tolterodine 57 Carvedilol 57 neurotoxicity 57 visilizumab 57 nicotinic 57 chemotherapeutics 57 Pioglitazone 57 immuno modulatory 57 Bicifadine 57 plasma pharmacokinetics 57 antiangiogenic therapy 57 pharmacologic therapy 57 calcitriol 57 receptor agonist 57 nadolol 57 thrombolytic agents 57 mitogenic 57 potent anti angiogenic 57 remyelination 57 vasoactive 57 anti arrhythmic 57 immunomodulator 57 plasma kallikrein 57 aminotransferases 57 adrenal suppression 57 GABA aminotransferase 57 anti anginal 57 Enkephalin 57 pimozide 57 intravenous bisphosphonates 57 dopamine transporter 57 dihydroergotamine 57 anticonvulsants 57 allopregnanolone 57 Tyrima 57 sulphonylureas 57 mixed hyperlipidemia 57 therapeutic modality 57 acadesine 57 kinase inhibition 57 neurologic progression 57 neuronal differentiation 57 hypertonic saline 57 JAK2 inhibitors 57 plasma lipid 57 anticholinergics 57 protamine 57 LMWH 57 PI3K inhibitor 57 metformin sulfonylurea 57 CG# [003] 57 anticancer agent 57 nociceptive 57 CA4P 57 CYP #A# 57 disease modifying antirheumatic 57 potent antiviral 57 iloprost 57 preclinical efficacy 57 LY# [002] 57 eNOS 57 enzyme inhibitors 57 levodopa induced 57 LATUDA 57 SERCA2a 57 antitumour 57 #HT#A 57 selective adenosine 57 nucleoside analogs 57 anti thrombotic 57 HIF 1a 57 myelosuppressive 57 activate p# 57 latanoprost 57 IFN alpha 57 HDAC inhibitors 57 gonadotrophin releasing hormone GnRH 57 BNC# 57 angiogenic therapy 57 intensive lipid lowering 57 preclinical models 57 L DOPA 57 bosentan 57 RISPERDAL ® 57 imatinib Gleevec 57 cholinergic 57 anticancer agents 57 Glucocorticoids 57 reuptake inhibitor 57 growth hormone secretion 57 Pimavanserin 57 treating neuropathic pain 57 baroreflex 57 neuroactive 57 receptor tyrosine kinase inhibitor 57 potent anticancer 57 davalintide 57 denervation 57 KRN# 57 varespladib 57 atypical neuroleptics 57 anticoagulation 57 proteasome inhibitors 57 mGluR2 NAM 57 antiangiogenic agent 57 EGFR inhibition 57 intra arterial 56 somatostatin analogues 56 OADs 56 Omacetaxine mepesuccinate 56 tanespimycin 56 ZFP TF 56 H2 antagonists 56 CYT# potent vascular disrupting 56 fluoxetine Prozac 56 small molecule inhibitors 56 ADAGIO study 56 plasma renin activity 56 inosine 56 mealtime insulin 56 postsurgical pain 56 fondaparinux 56 Preclinical studies suggest 56 diabetic nephropathy 56 baclofen 56 subcutaneously administered 56 vivo potency 56 QTc prolongation 56 hypercalcemia 56 γ secretase 56 somatostatin analogue 56 CCX# 56 adrenergic receptor 56 microtubule inhibitor 56 uricase 56 anthracycline chemotherapy 56 small molecule activators 56 PPARγ 56 ATACAND 56 insulin sensitization 56 pramipexole Mirapex 56 EGFR TKIs 56 fluticasone furoate 56 alteplase 56 COX inhibitors 56 dose cytarabine 56 stratifying patients 56 neurocognitive function 56 tolerability profiles 56 thetreatment 56 ENMD # 56 psychostimulants 56 estrogen receptor beta 56 Hsp# inhibition 56 PsA 56 resynchronization therapy 56 antianginal 56 Solulin 56 therapeutic armamentarium 56 antioxidant supplementation 56 rolipram 56 AST ALT 56 tolerability profile 56 nucleoside analog 56 nicardipine 56 androgenic 56 MEK inhibitors 56 mimetics 56 thrombopoietin 56 IOP lowering 56 ON #.Na 56 tipranavir 56 tocilizumab 56 pegylated 56 JAK2 inhibitor 56 agonists 56 Capesaris 56 lipoic acid 56 angiotensin receptor 56 Doxil ® 56 MAP# 56 Pharmacokinetic studies 56 TLR agonists 56 linear pharmacokinetics 56 Tasimelteon 56 insulin analogs 56 aripiprazole Abilify 56 fibrotic disease 56 renal fibrosis 56 ZOLINZA 56 LNP formulations 56 peritumoral brain edema 56 risperidone Risperdal 56 S/GSK# 56 histone deacetylase inhibitor 56 pressor response 56 PKC# 56 CYP#A# inhibitors 56 thiazolidinedione TZD 56 acamprosate 56 proteasome inhibitor 56 ropivacaine 56 selegiline 56 MoxDuo 56 hepatotoxicity 56 Atypical antipsychotics 56 iroxanadine 56 paroxetine Paxil 56 myocardial ischemia 56 thromboembolic disease 56 CIMZIA ™ 56 MAGE A3 ASCI 56 bronchodilator 56 potent antitumor 56 LTRA 56 FVIIa 56 immunomodulators 56 antidiabetic therapy 56 Perforomist ™ Inhalation Solution 56 IGFBP 3 56 cytotoxic 56 SIRT1 activation 56 SNRI 56 amylin 56 antitumor activity 56 tumor subtypes 56 Fulvestrant 56 olmesartan 56 Xanafide 56 DMARDs 56 secondary hyperparathyroidism 56 chronicity 56 guanfacine extended release 56 pregabalin Lyrica 56 sulindac 56 chemoprevention 56 Serdaxin 56 inhibitory effects 56 radiolabeled 56 recurrent glioblastoma multiforme 56 lipid altering 56 5 HT3 receptor 56 Hedgehog inhibitor 56 diabetic neuropathic pain 56 prophylactic therapy 56 HCV protease 56 cardiac contractility 56 Revimmune 56 serotonin reuptake inhibitor 56 Lixivaptan 56 hyperprolactinemia 56 receptor antagonist 56 antiarrhythmic drugs 56 vorinostat 56 decitabine 56 serum cortisol 56 comorbid depression 56 anti neoplastic 56 antiandrogens 56 CBLC# 56 JAK inhibitors 56 dopamine antagonists 56 oral rivaroxaban 56 neuropathic 56 Vilazodone 56 pentoxifylline 56 Mitoxantrone 56 systemic antifungal 56 receptor blockers 56 SILENOR 56 interferon ribavirin 56 zolmitriptan 56 Synavive 56 pretargeting 56 HuLuc# 56 canakinumab 56 T2DM 56 endothelin receptor 56 Fc receptor 56 postoperative ileus 56 endothelin antagonists 56 administered intranasally 56 pharmacological therapy 56 sd rxRNA 56 dopamine reuptake 56 docetaxel Taxotere 56 CNS depressant 56 tyrosine kinase inhibitor 56 renin angiotensin system 56 non pharmacological interventions 56 nucleoside analogues 56 inhibitor RG# 56 Factor VIIa 56 EGFr 56 angiogenesis inhibitor 56 glitazone class 56 bevacizumab Avastin ® 56 methylphenidate Ritalin 56 cleavable linker 56 teratogenic 56 Pharmacologic 56 TNF inhibitors 56 IAP inhibitor 56 taxanes 56 mirtazapine 56 glitazones 56 comorbid conditions 56 ganetespib 56 antiplatelet medications 56 pregabalin 56 dexanabinol 56 bezafibrate 56 brain penetrant 56 pathogenic mechanisms 56 intranasal formulation 56 haematologic 56 anti coagulant therapy 56 exendin 4 56 Methotrexate MTX 56 parkinsonian symptoms 56 opiate antagonist 56 opioid 56 inhaled iloprost 56 immunotoxins 56 subcutaneous insulin 56 glutamate receptors 56 trospium 56 argatroban 56 oral antidiabetic 56 antithrombotic agents 56 vitro studies 56 CYP#D# inhibitors 56 nonsteroidal 56 rhGH 56 agonist antagonist 56 hedgehog pathway 56 PREZISTA r 56 vasopressor 56 improves glycemic 56 nucleosides 56 antitumour activity 56 muscarinic receptors 56 5 HT2A 56 pouchitis 56 anti mitotic 56 antihypertensive medications 56 selective inhibitors 56 endoxifen 56 EGFR pathway 56 osteoarthritic 56 PDE7 inhibitors 56 intravenously administered 56 TMS Therapy 56 radiotherapy RT 56 oral antiplatelet 56 Lacosamide 56 pharmacokinetic 56 mdx mice 56 somatostatin analog 56 cediranib 56 NF kappaB activation 56 cognitive behavioral therapies 56 PSN# [001] 56 myocardial 56 Panzem R NCD 56 triptans 56 platelet inhibition 56 Anticholinergic 56 biomarkers 56 sigma receptor 56 pulmonary hypertension PH 56 CD# antibody [001] 56 Bendavia 56 tranylcypromine 56 Hsp# inhibitor 56 dyslipidemia 56 postoperative AF 56 fibrinolytics 56 nociceptive pain 56 tigecycline 56 atherogenesis 56 AT1R 56 gamma secretase inhibitors 56 arterial thrombosis 56 granisetron 56 Quetiapine 56 NNT = 56 chemotherapeutic 56 opioid agonists 56 imatinib Gleevec ® 56 DACH platinum 56 physiologic mechanisms 56 variceal bleeding 56 myopathy rhabdomyolysis 56 Venlafaxine 56 boosted protease inhibitor 56 kallikrein 56 Combination therapy 55 Vimpat ® 55 thrombolytics 55 CTGF 55 cannabinoid 55 induce apoptosis 55 siRNA mediated 55 nutlin 55 opioids 55 SSRI antidepressant 55 orally bioavailable 55 severe gastroparesis 55 PPAR agonist 55 effector function 55 adjunctive 55 vessel occlusion 55 pramipexole 55 p# inhibitors 55 quetiapine Seroquel 55 proteoglycan 55 palliation 55 D2 receptor 55 dobutamine 55 infliximab Remicade 55 natriuretic peptides 55 Rasagiline 55 potency selectivity 55 menstrual migraine 55 rtPA 55 tipifarnib 55 antihypertensives 55 HMG CoA reductase inhibitor 55 ergot alkaloids 55 inverse agonists 55 optimal dosing 55 recombinant erythropoietin 55 antipsychotic efficacy 55 CGEN # 55 VA# [002] 55 levodopa carbidopa 55 aspirin clopidogrel 55 hormonal therapies 55 nitric oxide synthase 55 cidofovir 55 COX enzymes 55 LSI #P 55 RANK Ligand 55 contractility 55 nephrotoxicity 55 oral anticoagulant 55 refractory angina 55 sorafenib Nexavar 55 CTAP# Capsules 55 histone acetylation 55 topical NSAIDs 55 Methylnaltrexone 55 cMET 55 imatinib resistance 55 Corticosteroids 55 DMARDS 55 drug zotarolimus 55 dasatinib Sprycel 55 imatinib therapy 55 psychopharmacological 55 substrates inhibitors 55 glutamatergic 55 P#X# 55 YONDELIS 55 subtype selective 55 KL4 surfactant 55 Itraconazole 55 triphendiol 55 NATRECOR ® 55 nimodipine 55 BoNTA 55 inhaled anesthetics 55 antidiabetic agents 55 nonrandomized 55 analgesia 55 immunological responses 55 pomalidomide 55 selective agonists 55 Notch1 55 bexarotene 55 INCB# [001] 55 pharmacologically active 55 electroencephalographic 55 excitotoxic 55 gabapentin Neurontin 55 endogenous opioid 55 leukotriene receptor antagonist 55 LY# [003] 55 glucocorticoids 55 ISIS # 55 antiplatelet drugs 55 myocardial tissue 55 PlGF 55 mediated inhibition 55 TGF beta signaling 55 TKI therapy 55 uridine triacetate 55 antineoplastic 55 surrogate endpoint 55 LT NS# 55 buspirone 55 pertussis toxin 55 Gleevec resistant 55 pharmacokinetic profile 55 NATRECOR R 55 intravesical therapy 55 resolvins 55 PEGylated 55 Candesartan 55 fibrinolysis 55 NSAID induced 55 anakinra 55 PTP 1B 55 biologic pathways 55 MAOI 55 intranasal delivery 55 long acting bronchodilators 55 Antiangiogenic 55 nicotinic receptor 55 hepatic fibrosis 55 angina pectoris 55 vildagliptin 55 oral anticoagulants 55 Insulin PH# 55 allergic inflammation 55 macrolide antibiotics 55 Valproic acid 55 therapeutically 55 ursodeoxycholic acid 55 Pegylated Interferon 55 CRx 55 liver fibrosis 55 anticoagulant warfarin 55 C1 INH 55 superficial bladder cancer 55 orally dosed 55 anti androgens 55 CEACAM1 55 Combo Stent 55 Enzastaurin 55 rBChE 55 QTc intervals 55 receptor activation 55 biodistribution 55 IGF 1R